Structural brain alterations before mild cognitive impairment in ADNI: Validation of volume loss in a predefined antero-temporal region

Journal of Alzheimer's Disease

Volumn 31, Issue SUPPL. 3, 2012, Pages

  Smith, Charles D ^a,b,c   Andersen, Anders H ^a,c   Gold, Brian T ^a,b,c  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Alzheimer's disease neuroimaging initiative; Alzheimer's disease risk; amygdala; brain aging; hippocampus; longitudinal studies; magnetic resonance imaging; medial temporal lobe; structural neuroimaging; voxel based morphometry

Indexed keywords

AGED; ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; ARTICLE; BRAIN REGION; BRAIN SIZE; CONTROLLED STUDY; FEMALE; GRAY MATTER; HUMAN; IMAGE PROCESSING; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; NEUROIMAGING; POSTERIOR CINGULATE; PRIORITY JOURNAL; TEMPORAL LOBE;

EID: 84866868566     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2012-120157     Document Type: Article

References (33)

1. Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Iwatsubo T, Jack CR Jr, Kaye J, Montine TJ, Park DC, Reiman EM, Rowe CC, Siemers E, Stern Y, Yaffe K, Carrillo MC, Thies B, Morrison-Bogorad M, Wagster MV, Phelps CH (2011) Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the national institute on aging-Alzheimer's association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7, 280-292.
2. Jack CR Jr, Vemuri P, Wiste HJ, Weigand SD, Aisen PS, Trojanowski JQ, Shaw LM, Bernstein MA, Petersen RC, Weiner MW, Knopman DS (2011) Evidence for ordering of Alzheimer disease biomarkers. Arch Neurol 68, 1526-1535.
3. Smith CD (2011) Structural imaging in early pre-states of dementia. Biochim Biophys Acta 1822, 317-324.
4. Smith CD (2010) Neuroimaging through the course of Alzheimer's disease. J Alzheimers Dis 19, 273-290.
5. Becker JA, Hedden T, Carmasin J, Maye J, Rentz DM, Putcha D, Fischl B, Greve DN, Marshall GA, Salloway S, Marks D, Buckner RL, Sperling RA, Johnson KA (2011) Amyloid-beta associated cortical thinning in clinically normal elderly. Ann Neurol 69, 1032-1042.
6. Bourgeat P, Chetelat G, Villemagne VL, Fripp J, Raniga P, Pike K, Acosta O, Szoeke C, Ourselin S, Ames D, Ellis KA, Martins RN, Masters CL, Rowe CC, Salvado O, Group AR (2010) Beta-amyloid burden in the temporal neocortex is related to hippocampal atrophy in elderly subjects without dementia. Neurology 74, 121-127.
7. Storandt M, Mintun MA, Head D, Morris JC (2009) Cognitive decline and brain volume loss as signatures of cerebral amyloid-beta peptide deposition identified with Pittsburgh compound B: Cognitive decline associated with Abeta deposition. Arch Neurol 66, 1476-1481.
8. Carlson NE, Moore MM, Dame A, Howieson D, Silbert LC, Quinn JF, Kaye JA (2008) Trajectories of brain loss in aging and the development of cognitive impairment. Neurology 70, 828-833.
9. Murphy EA, Holland D, Donohue M, McEvoy LK, Hagler DJ Jr, Dale AM, Brewer JB, Alzheimer's Disease Neuroimaging I (2010) Six-month atrophy in MTL structures is associated with subsequent memory decline in elderly controls. Neuroimage 53, 1310-1317.
10. Rusinek H, De Santi S, Frid D, Tsui WH, Tarshish CY, Convit A, de Leon MJ (2003) Regional brain atrophy rate predicts future cognitive decline: 6-year longitudinal MR imaging study of normal aging. Radiology 229, 691-696.
11. Jack CR Jr, Shiung MM, Weigand SD, O'Brien PC, Gunter JL, Boeve BF, Knopman DS, Smith GE, Ivnik RJ, Tangalos EG, Petersen RC (2005) Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI. Neurology 65, 1227-1231.
12. Apostolova LG, Mosconi L, Thompson PM, Green AE, Hwang KS, Ramirez A, Mistur R, Tsui WH, de Leon MJ (2008) Subregional hippocampal atrophy predicts Alzheimer's dementia in the cognitively normal. Neurobiol Aging 31, 1077-1088.
13. den Heijer T, Geerlings MI, Hoebeek FE, Hofman A, Koudstaal PJ, Breteler MM (2006) Use of hippocampal and amygdalar volumes on magnetic resonance imaging to predict dementia in cognitively intact elderly people. Arch Gen Psychiatry 63, 57-62.
14. den Heijer T, van der Lijn F, Koudstaal PJ, Hofman A, van der Lugt A, Krestin GP, Niessen WJ, Breteler MM (2010) A 10-year follow-up of hippocampal volume on magnetic resonance imaging in early dementia and cognitive decline. Brain 133, 1163-1172.
15. Hua X, Leow AD, Parikshak N, Lee S, Chiang MC, Toga AW, Jack CR Jr,WeinerMW, Thompson PM (2008) Tensor-based morphometry as a neuroimaging biomarker for Alzheimer's disease: An MRI study of 676 AD, MCI, and normal subjects. Neuroimage 43, 458-469.
16. Kaye JA, Swihart T, Howieson D, Dame A, Moore MM, Karnos T, Camicioli R, Ball M, Oken B, Sexton G (1997) Volume loss of the hippocampus and temporal lobe in healthy elderly persons destined to develop dementia. Neurology 48, 1297-1304.
17. Smith CD, Chebrolu H, Wekstein DR, Schmitt FA, Jicha GA, Cooper G, Markesbery WR (2007) Brain structural alterations before mild cognitive impairment. Neurology 68, 1268-1273.
18. Martin SB, Smith CD, Collins HR, Schmitt FA, Gold BT (2010) Evidence that volume of anterior medial temporal lobe is reduced in seniors destined for mild cognitive impairment. Neurobiol Aging 31, 1099-1106.
19. Chiang GC, Insel PS, Tosun D, Schuff N, Truran-Sacrey D, Raptentsetsang S, Jack CR Jr,WeinerMW(2011) Identifying cognitively healthy elderly individuals with subsequent memory decline by using automatedMRtemporoparietal volumes. Radiology 259, 844-851.
20. Jagust W, Gitcho A, Sun F, Kuczynski B, Mungas D, Haan M (2006) Brain imaging evidence of preclinical Alzheimer's disease in normal aging. Ann Neurol 59, 673-681.
21. Dickerson BC, Stoub TR, Shah RC, Sperling RA, Killiany RJ, Albert MS, Hyman BT, Blacker D, Detoledo-Morrell L (2011) Alzheimer-signature MRI biomarker predicts AD dementia in cognitively normal adults. Neurology 76, 1395- 1402.
22. Mueller SG, Weiner MW, Thal LJ, Petersen RC, Jack CR, Jagust W, Trojanowski JQ, Toga AW, Beckett L (2005) Ways toward an early diagnosis in Alzheimer's disease: The Alzheimer's Disease Neuroimaging Initiative (ADNI). Alzheimers Dement 1, 55-66.
23. Folstein MF, Folstein SE, McHugh PR (1975) "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12, 189-198.
24. Morris JC (1993) The Clinical Dementia Rating (CDR): Current version and scoring rules. Neurology 43, 2412-2414.
25. Wechsler D (1987) Wms-RWeschsler Memory Scale: Revised Manual, The Psychological Corporation, Harcort Brace Jovanovich, New York, NY
26. Mugler JP, 3rd, Brookeman JR (1991) Rapid threedimensional T1-weighted MR imaging with the MP-RAGE sequence. J Magn Reson Imaging 1, 561-567.
27. Sled JG, Zijdenbos AP, Evans AC (1998) A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans Med Imaging 17, 87-97.
28. Ashburner J, Friston K (1997) Multimodal image coregistration and partitioning-a unified framework. Neuroimage 6, 209-217.
29. Ashburner J, Friston KJ (2005) Unified segmentation. Neuroimage 26, 839-851.
30. Ashburner J, Neelin P, Collins DL, Evans A, Friston K (1997) Incorporating prior knoedge into image registration. Neuroimage 6, 344-352.
31. Fagiolo G, Waldman A, Hajnal JV (2008) A simple procedure to improve FMRIb software library brain extraction tool performance. Br J Radiol 81, 250-251.
32. Rosenberg SJ, Ryan JJ, PrifiteraA(1984) Rey auditory-verbal learning test performance of patients with and without memory impairment. J Clin Psychol 40, 785-787.
33. Sano M, Raman R, Emond J, Thomas RG, Petersen R, Schneider LS, Aisen PS (2011) Adding delayed recall to the Alzheimer disease assessment scale is useful in studies of mild cognitive impairment but not Alzheimer disease. Alzheimer Dis Assoc Disord 25, 122-127.